<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38396973</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Autoimmune Autonomic Neuropathy: From Pathogenesis to Diagnosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2296</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25042296</ELocationID><Abstract><AbstractText>Autoimmune autonomic ganglionopathy (AAG) is a disease of autonomic failure caused by ganglionic acetylcholine receptor (gAChR) autoantibodies. Although the detection of autoantibodies is important for distinguishing the disease from other neuropathies that present with autonomic dysfunction, other factors are important for accurate diagnosis. Here, we provide a comprehensive review of the clinical features of AAG, highlighting differences in clinical course, clinical presentation, and laboratory findings from other neuropathies presenting with autonomic symptoms. The first step in diagnosing AAG is careful history taking, which should reveal whether the mode of onset is acute or chronic, followed by an examination of the time course of disease progression, including the presentation of autonomic and extra-autonomic symptoms. AAG is a neuropathy that should be differentiated from other neuropathies when the patient presents with autonomic dysfunction. Immune-mediated neuropathies, such as acute autonomic sensory neuropathy, are sometimes difficult to differentiate, and therefore, differences in clinical and laboratory findings should be well understood. Other non-neuropathic conditions, such as postural orthostatic tachycardia syndrome, chronic fatigue syndrome, and long COVID, also present with symptoms similar to those of AAG. Although often challenging, efforts should be made to differentiate among the disease candidates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakane</LastName><ForeName>Shunya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1958-095X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Haruki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakatsuji</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22FC1007</GrantID><Agency>Ministry of Health Labour and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005725" MajorTopicYN="N">Ganglia, Autonomic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020274" MajorTopicYN="Y">Autoimmune Diseases of the Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001342" MajorTopicYN="Y">Autonomic Nervous System Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010523" MajorTopicYN="Y">Peripheral Nervous System Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">autoimmune autonomic ganglionopathy</Keyword><Keyword MajorTopicYN="N">extra-autonomic manifestations</Keyword><Keyword MajorTopicYN="N">ganglionic acetylcholine receptor</Keyword><Keyword MajorTopicYN="N">immunotherapy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38396973</ArticleId><ArticleId IdType="pmc">PMC10889307</ArticleId><ArticleId IdType="doi">10.3390/ijms25042296</ArticleId><ArticleId IdType="pii">ijms25042296</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vernino S., Adamski J., Kryzer T.J., Fealey R.D., Lennon V.A. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 1998;50:1806&#x2013;1813. doi: 10.1212/WNL.50.6.1806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.50.6.1806</ArticleId><ArticleId IdType="pubmed">9633732</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 2000;343:847&#x2013;855. doi: 10.1056/NEJM200009213431204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200009213431204</ArticleId><ArticleId IdType="pubmed">10995864</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon V.A., Ermilov L.G., Szurszewski J.H., Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Investig. 2003;111:907&#x2013;913. doi: 10.1172/JCI17429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI17429</ArticleId><ArticleId IdType="pmc">PMC153771</ArticleId><ArticleId IdType="pubmed">12639997</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Low P.A., Lennon V.A. Experimental autoimmune autonomic neuropathy. J. Neurophysiol. 2003;90:2053&#x2013;2059. doi: 10.1152/jn.00408.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00408.2003</ArticleId><ArticleId IdType="pubmed">12773498</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Ermilov L.G., Sha L., Szurszewski J.H., Low P.A., Lennon V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 2004;24:7037&#x2013;7042. doi: 10.1523/JNEUROSCI.1485-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1485-04.2004</ArticleId><ArticleId IdType="pmc">PMC1196355</ArticleId><ArticleId IdType="pubmed">15306637</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Low P.A., Jordan J., Freeman R., Gibbons C.H., Schroeder C., Sandroni P., Vernino S. Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology. 2007;68:1917&#x2013;1921. doi: 10.1212/01.wnl.0000263185.30294.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000263185.30294.61</ArticleId><ArticleId IdType="pmc">PMC2615674</ArticleId><ArticleId IdType="pubmed">17536048</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Sandroni P., Singer W., Low P.A. Invited Article: Autonomic ganglia: Target and novel therapeutic tool. Neurology. 2008;70:1926&#x2013;1932. doi: 10.1212/01.wnl.0000312280.44805.5d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000312280.44805.5d</ArticleId><ArticleId IdType="pmc">PMC2637993</ArticleId><ArticleId IdType="pubmed">18474849</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Hopkins S., Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton. Neurosci. 2009;146:3&#x2013;7. doi: 10.1016/j.autneu.2008.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2008.09.005</ArticleId><ArticleId IdType="pmc">PMC2677210</ArticleId><ArticleId IdType="pubmed">18951069</ArticleId></ArticleIdList></Reference><Reference><Citation>Iodice V., Kimpinski K., Vernino S., Sandroni P., Fealey R.D., Low P.A. Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology. 2009;72:2002&#x2013;2008. doi: 10.1212/WNL.0b013e3181a92b52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a92b52</ArticleId><ArticleId IdType="pmc">PMC2837591</ArticleId><ArticleId IdType="pubmed">19506222</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane S., Higuchi O., Koga M., Kanda T., Murata K., Suzuki T., Kurono H., Kunimoto M., Kaida K., Mukaino A., et al. Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients. PLoS ONE. 2015;10:e0118312. doi: 10.1371/journal.pone.0118312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118312</ArticleId><ArticleId IdType="pmc">PMC4366081</ArticleId><ArticleId IdType="pubmed">25790156</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane S., Mukaino A., Higuchi O., Yasuhiro M., Takamatsu K., Yamakawa M., Watari M., Tawara N., Nakahara K.I., Kawakami A., et al. A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy. J. Autoimmun. 2020;108:102403. doi: 10.1016/j.jaut.2020.102403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102403</ArticleId><ArticleId IdType="pubmed">31924415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M., Nakane S., Ihara E., Tawara N., Ikeda H., Igarashi Y., Komohara Y., Takamatsu K., Ikeda T., Tomita Y., et al. A novel murine model of autoimmune dysautonomia by &#x3b1;3 nicotinic acetylcholine receptor immunization. Front. Neurosci. 2022;16:1006923. doi: 10.3389/fnins.2022.1006923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.1006923</ArticleId><ArticleId IdType="pmc">PMC9727251</ArticleId><ArticleId IdType="pubmed">36507326</ArticleId></ArticleIdList></Reference><Reference><Citation>Urriola N., Spies J.M., Blazek K., Lang B., Adelstein S. A flow cytometric assay to detect functional ganglionic acetylcholine receptor antibodies by immunomodulation in autoimmune autonomic ganglionopathy. Front. Immunol. 2021;12:705292. doi: 10.3389/fimmu.2021.705292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.705292</ArticleId><ArticleId IdType="pmc">PMC8261233</ArticleId><ArticleId IdType="pubmed">34249013</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiorgou K., Dandoulaki M., Mantegazza R., Andreetta F., Furlan R., Lindstrom J., Zisimopoulou P., Chroni E., Kokotis P., Anagnostou E., et al. Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1162. doi: 10.1212/NXI.0000000000001162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001162</ArticleId><ArticleId IdType="pmc">PMC8969289</ArticleId><ArticleId IdType="pubmed">35351814</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike H., Watanabe H., Sobue G. The spectrum of immune-mediated autonomic neuropathies: Insights from the clinicopathological features. J. Neurol. Neurosurg. Psychiatry. 2013;84:98&#x2013;106. doi: 10.1136/jnnp-2012-302833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302833</ArticleId><ArticleId IdType="pubmed">22906617</ArticleId></ArticleIdList></Reference><Reference><Citation>Urriola N., Lang B., Adelstein S. Evaluation of commercially available antibodies and fluorescent conotoxins for the detection of surface ganglionic acetylcholine receptor on the neuroblastoma cell line, IMR-32 by flow cytometry. J. Immunol. Methods. 2021;498:113124. doi: 10.1016/j.jim.2021.113124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2021.113124</ArticleId><ArticleId IdType="pubmed">34425081</ArticleId></ArticleIdList></Reference><Reference><Citation>Pechlivanidou M., Ninou E., Karagiorgou K., Tsantila A., Mantegazza R., Francesca A., Furlan R., Dudeck L., Steiner J., Tzartos J., et al. Autoimmunity to neuronal nicotinic acetylcholine receptors. Pharmacol. Res. 2023;192:106790. doi: 10.1016/j.phrs.2023.106790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2023.106790</ArticleId><ArticleId IdType="pubmed">37164280</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti-Fine B.M., Milani M., Kaminski H.J. Myasthenia gravis: Past, present, and future. J. Clin. Investig. 2006;116:2843&#x2013;2854. doi: 10.1172/JCI29894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29894</ArticleId><ArticleId IdType="pmc">PMC1626141</ArticleId><ArticleId IdType="pubmed">17080188</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson S.R., Romero M.F., Popescu B.F., Lucchinetti C.F., Fryer J.P., Wolburg H., Fallier-Becker P., Noell S., Lennon V.A. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc. Natl. Acad. Sci. USA. 2012;109:1245&#x2013;1250. doi: 10.1073/pnas.1109980108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109980108</ArticleId><ArticleId IdType="pmc">PMC3268278</ArticleId><ArticleId IdType="pubmed">22128336</ArticleId></ArticleIdList></Reference><Reference><Citation>Watari M., Nakane S., Mukaino A., Nakajima M., Mori Y., Maeda Y., Masuda T., Takamatsu K., Kouzaki Y., Higuchi O., et al. Autoimmune postural orthostatic tachycardia syndrome. Ann. Clin. Transl. Neurol. 2018;5:486&#x2013;492. doi: 10.1002/acn3.524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.524</ArticleId><ArticleId IdType="pmc">PMC5899914</ArticleId><ArticleId IdType="pubmed">29687025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yu X., Liles C., Khan M., Vanderlinde-Wood M., Galloway A., Zillner C., Benbrook A., Reim S., Collier D., et al. Autoimmune basis for postural tachycardia syndrome. J. Am. Heart Assoc. 2014;3:e000755. doi: 10.1161/JAHA.113.000755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000755</ArticleId><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Li H., Yu X., Koelsch K.A., Harris V.M., Liles C., Murphy T.A., Quadri S.M.S., Scofield R.H., Sutton R., et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017;19:1211&#x2013;1219. doi: 10.1093/europace/euw154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euw154</ArticleId><ArticleId IdType="pmc">PMC5834103</ArticleId><ArticleId IdType="pubmed">27702852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedi S.N., Kalaria T., Buch H. Thyroid autoantibodies. J. Clin. Pathol. 2023;76:19&#x2013;28. doi: 10.1136/jcp-2022-208290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp-2022-208290</ArticleId><ArticleId IdType="pubmed">36270794</ArticleId></ArticleIdList></Reference><Reference><Citation>Makita N., Ando T., Sato J., Manaka K., Mitani K., Kikuchi Y., Niwa T., Ootaki M., Takeba Y., Matsumoto N., et al. Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody. JCI Insight. 2019;4:e126449. doi: 10.1172/jci.insight.126449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.126449</ArticleId><ArticleId IdType="pmc">PMC6538321</ArticleId><ArticleId IdType="pubmed">30996138</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch E.E. The clinical approach to autonomic failure in neurological disorders. Nat. Rev. Neurol. 2014;10:396&#x2013;407. doi: 10.1038/nrneurol.2014.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.88</ArticleId><ArticleId IdType="pubmed">24866874</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M., Watari M., Torii K.I., Kuki I., Miharu M., Kawazu M., Mukaino A., Higuchi O., Maeda Y., Ikeda T., et al. gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan. Ann. Clin. Transl. Neurol. 2021;8:790&#x2013;799. doi: 10.1002/acn3.51317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51317</ArticleId><ArticleId IdType="pmc">PMC8045944</ArticleId><ArticleId IdType="pubmed">33621398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuki I., Kawawaki H., Okazaki S., Hattori Y., Horino A., Higuchi O., Nakane S. Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis. Brain Dev. 2016;38:605&#x2013;608. doi: 10.1016/j.braindev.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.braindev.2015.12.009</ArticleId><ArticleId IdType="pubmed">26740077</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N., Takahashi S., Inaba T., Takamiya M., Kageyama Y., Morimoto M., Takahashi Y., Nishimura H., Nakane S., Abe K. A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm. J. Clin. Neurosci. 2017;39:90&#x2013;92. doi: 10.1016/j.jocn.2017.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.01.027</ArticleId><ArticleId IdType="pubmed">28214088</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane S., Mukaino A., Maeda Y., Higuchi O., Matsuo H., Ando Y. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: A Japanese survey. J. Neurol. Neurosurg. Psychiatry. 2017;88:367&#x2013;368. doi: 10.1136/jnnp-2016-314707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314707</ArticleId><ArticleId IdType="pubmed">27837100</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi M., Ishii Y. A Japanese case of autoimmune autonomic ganglionopathy (AAG) and a review of AAG cases in Japan. Auton. Neurosci. 2009;146:26&#x2013;28. doi: 10.1016/j.autneu.2008.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2008.12.013</ArticleId><ArticleId IdType="pubmed">19195935</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker S.K., Morillo C., Vernino S. Autoimmune autonomic ganglionopathy with late-onset encephalopathy. Auton. Neurosci. 2009;146:29&#x2013;32. doi: 10.1016/j.autneu.2008.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2008.10.016</ArticleId><ArticleId IdType="pubmed">19028442</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons C.H., Centi J., Vernino S., Freeman R. Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch. Neurol. 2012;69:461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3359761</ArticleId><ArticleId IdType="pubmed">22158721</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda M., Morimoto T., Matsuda H., Nagao H., Wakamoto H., Ohnishi A. A case of acute idiopathic pandysautonomia with SIADH. No Hattatsu. 1995;27:41&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">7873251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaino A., Nakane S., Higuchi O., Nakamura H., Miyagi T., Shiroma K., Tokashiki T., Fuseya Y., Ochi K., Umeda M., et al. Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sj&#xf6;gren&#x2019;s syndrome. Mod. Rheumatol. 2016;26:708&#x2013;715. doi: 10.3109/14397595.2016.1147404.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14397595.2016.1147404</ArticleId><ArticleId IdType="pubmed">26873295</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y., Nakane S., Higuchi O., Nakamura H., Komori A., Migita K., Mukaino A., Umeda M., Ichinose K., Tamai M., et al. Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis. Mod. Rheumatol. 2017;27:664&#x2013;668. doi: 10.1080/14397595.2016.1226469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14397595.2016.1226469</ArticleId><ArticleId IdType="pubmed">27538899</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike H., Atsuta N., Adachi H., Iijima M., Katsuno M., Yasuda T., Fukada Y., Yasui K., Nakashima K., Horiuchi M., et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain. 2010;133:2881&#x2013;2896. doi: 10.1093/brain/awq214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq214</ArticleId><ArticleId IdType="pubmed">20736188</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y., Motegi T., Yuasa T., Atsumi T., Miyatake T. Acute autonomic and sensory neuropathy associated with galactorrhea-amenorrhea syndrome and intractable anorexia. Rinsho Shinkeigaku. 1989;29:1265&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">2557996</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H., Mukai E., Okuda S., Kawada T. A severe case of acute autonomic and sensory neuropathy. Rinsho Shinkeigaku. 1998;38:663&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">9868313</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Doorn P.A., Ruts L., Jacobs B.C. Clinical features, pathogenesis, and treatment of Guillain-Barr&#xe9; syndrome. Lancet Neurol. 2008;7:939&#x2013;950. doi: 10.1016/S1474-4422(08)70215-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70215-1</ArticleId><ArticleId IdType="pubmed">18848313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaeem Z., Siddiqi Z.A., Zochodne D.W. Autonomic involvement in Guillain-Barr&#xe9; syndrome: An update. Clin. Auton. Res. 2019;29:289&#x2013;299. doi: 10.1007/s10286-018-0542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-018-0542-y</ArticleId><ArticleId IdType="pubmed">30019292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty T., Kramer C.L., Wijdicks E.F.M., Rabinstein A.A. Dysautonomia in Guillain-Barr&#xe9; Syndrome: Prevalence, Clinical Spectrum, and Outcomes. Neurocrit. Care. 2020;32:113&#x2013;120. doi: 10.1007/s12028-019-00781-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-019-00781-w</ArticleId><ArticleId IdType="pubmed">31297663</ArticleId></ArticleIdList></Reference><Reference><Citation>Baz&#xe1;n-Rodr&#xed;guez L., Ruiz-Avalos J.A., de Sar&#xe1;chaga A.J., Martinez-Jimenez E., L&#xf3;pez-Hern&#xe1;ndez J.C., Vargas-Ca&#xf1;as S. Dysautonomia and related outcomes in Guillain-Barre syndrome. Auton. Neurosci. 2023;245:103070. doi: 10.1016/j.autneu.2022.103070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2022.103070</ArticleId><ArticleId IdType="pubmed">36634383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropper A.H., Wijdicks E.F.M., Truax B.T. Guillain&#x2013;Barr&#xe9; Syndrome. FA Davis; Philadelphia, PA, USA: 1991. Clinical features of the typical syndrome; pp. 73&#x2013;105.</Citation></Reference><Reference><Citation>Rzepi&#x144;ski &#x141;., Doneddu P.E., Cutell&#xe8; C., Zawadka-Kunikowska M., Nobile-Orazio E. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: A literature review. Neurol. Sci. 2023;44:3071&#x2013;3082. doi: 10.1007/s10072-023-06802-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-023-06802-z</ArticleId><ArticleId IdType="pubmed">37083958</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamboulis E., Katsaros N., Koutsis G., Iakovidou H., Giannakopoulou A., Simintzi I. Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2006;33:78&#x2013;84. doi: 10.1002/mus.20438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20438</ArticleId><ArticleId IdType="pubmed">16184605</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa J.J., Dyck P.J., Laughlin R.S., Mercado J.A., Massie R., Sandroni P., Dyck P.J., Low P.A. Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2012;78:702&#x2013;708. doi: 10.1212/WNL.0b013e3182494d66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182494d66</ArticleId><ArticleId IdType="pmc">PMC3306161</ArticleId><ArticleId IdType="pubmed">22357716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd D.P. Neurosarcoidosis: Clinical manifestations, investigation and treatment. Pract. Neurol. 2020;20:199&#x2013;212. doi: 10.1136/practneurol-2019-002349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2019-002349</ArticleId><ArticleId IdType="pubmed">32424017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw M.J., Pawate S., Koth L.L., Cho T.A., Gelfand J.M. Neurosarcoidosis: Pathophysiology, diagnosis, and treatment. Neurol. Neuroimmunol. Neuroinflamm. 2021;8:e1084. doi: 10.1212/NXI.0000000000001084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001084</ArticleId><ArticleId IdType="pmc">PMC8495503</ArticleId><ArticleId IdType="pubmed">34607912</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavee J.O., Karwa K., Ahmed Z., Thompson N., Parambil J., Culver D.A. Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment. Respir. Med. 2017;126:135&#x2013;138. doi: 10.1016/j.rmed.2017.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2017.03.011</ArticleId><ArticleId IdType="pubmed">28318820</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi M., Mukaino A., Kunii M., Saito A., Arita Y., Koike H., Higuchi O., Maeda Y., Abiru N., Yamaguchi N., et al. Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. J. Neurol. 2021;268:4265&#x2013;4279. doi: 10.1007/s00415-021-10551-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10551-4</ArticleId><ArticleId IdType="pmc">PMC8505292</ArticleId><ArticleId IdType="pubmed">33881596</ArticleId></ArticleIdList></Reference><Reference><Citation>Binks S., Uy C., Honnorat J., Irani S.R. Paraneoplastic neurological syndromes: A practical approach to diagnosis and management. Pract. Neurol. 2022;22:19&#x2013;31. doi: 10.1136/practneurol-2021-003073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2021-003073</ArticleId><ArticleId IdType="pubmed">34510016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso L., Hart I.K., Ferrari D., Ngonga G.K., Gasparetto C., Ricevuti G. Autonomic paraneoplastic neurological syndromes. Autoimmun. Rev. 2007;6:162&#x2013;168. doi: 10.1016/j.autrev.2006.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2006.10.003</ArticleId><ArticleId IdType="pubmed">17289552</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazaki C., Hata H., Iida S., Ueda M., Katoh N., Sekijima Y., Ikeda S., Yazaki M., Fukushima W., Ando Y. Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan. Intern. Med. 2018;57:181&#x2013;187. doi: 10.2169/internalmedicine.9206-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.9206-17</ArticleId><ArticleId IdType="pmc">PMC5820034</ArticleId><ArticleId IdType="pubmed">29093404</ArticleId></ArticleIdList></Reference><Reference><Citation>Maule S., Quadri R., Mirante D., Pellerito R.A., Marucco E., Marinone C., Vergani D., Chiandussi L., Zanone M.M. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): Possible pathogenic role of autoantibodies to autonomic nervous structures. Clin. Exp. Immunol. 1997;110:423&#x2013;427. doi: 10.1046/j.1365-2249.1997.4501466.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1997.4501466.x</ArticleId><ArticleId IdType="pmc">PMC1904812</ArticleId><ArticleId IdType="pubmed">9409646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino D., Naclerio C., Iengo R., D&#x2019;Angelo S., Cuomo G., Valentini G. Cardiac autonomic dysfunction precedes the development of fibrosis in patients with systemic sclerosis. Rheumatology. 2002;41:586&#x2013;588. doi: 10.1093/rheumatology/41.5.586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/41.5.586</ArticleId><ArticleId IdType="pubmed">12011386</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton J.L., Frith J., Powell D., Hackett K., Wilton K., Bowman S., Price E., Pease C., Andrews J., Emery P., et al. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren&#x2019;s syndrome. Ann. Rheum. Dis. 2012;71:1973&#x2013;1979. doi: 10.1136/annrheumdis-2011-201009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-201009</ArticleId><ArticleId IdType="pmc">PMC3488764</ArticleId><ArticleId IdType="pubmed">22562982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl T., Wollmer P., Manthorpe R., Jacobsson L.T. Autonomic and orthostatic dysfunction in primary Sj&#xf6;gren&#x2019;s syndrome. J. Rheumatol. 2007;34:1869&#x2013;1874.</Citation><ArticleIdList><ArticleId IdType="pubmed">17659755</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K., Ng W.F. Autonomic nervous system dysfunction in primary Sj&#xf6;gren&#x2019;s syndrome. Front. Immunol. 2021;12:702505. doi: 10.3389/fimmu.2021.702505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.702505</ArticleId><ArticleId IdType="pmc">PMC8350514</ArticleId><ArticleId IdType="pubmed">34381453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mravec B. Autonomic dysfunction in autoimmune diseases: Consequence or cause? Lupus. 2007;16:767&#x2013;768. doi: 10.1177/0961203307081843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203307081843</ArticleId><ArticleId IdType="pubmed">17728374</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovich L., Milovanovich B., de Luka S.R., Popovich-Kuzmanovich D., Bisenich V., Djukanovich B., Randjelovich T., Krotin M. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sj&#xf6;gren syndrome and other autoimmune diseases. Lupus. 2007;16:181&#x2013;185. doi: 10.1177/0961203306076223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203306076223</ArticleId><ArticleId IdType="pubmed">17432103</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun. Rev. 2009;8:569&#x2013;572. doi: 10.1016/j.autrev.2009.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.01.018</ArticleId><ArticleId IdType="pubmed">19393212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumida T., Tsuboi H., Iizuka M., Asashima H., Matsumoto I. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sj&#xf6;gren&#x2019;s syndrome. Mod. Rheumatol. 2013;23:841&#x2013;845. doi: 10.3109/s10165-012-0788-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/s10165-012-0788-5</ArticleId><ArticleId IdType="pubmed">23135882</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura M., Mukaino A., Takamatsu K., Tsuboi H., Higuchi O., Nakamura H., Abe S., Ando Y., Matsuo H., Nakamura T., et al. Ganglionic acetylcholine receptor antibodies and autonomic dysfunction in autoimmune rheumatic diseases. Int. J. Mol. Sci. 2020;21:1332. doi: 10.3390/ijms21041332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041332</ArticleId><ArticleId IdType="pmc">PMC7073227</ArticleId><ArticleId IdType="pubmed">32079137</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson L., Tobin A., Smith P., Gordon T. Antimuscarinic antibodies in Sj&#xf6;gren&#x2019;s syndrome: Where are we, and where are we going? Arthritis Rheum. 2005;52:2984&#x2013;2995. doi: 10.1002/art.21347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21347</ArticleId><ArticleId IdType="pubmed">16200578</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinik A.I., Maser R.E., Mitchell B.D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553&#x2013;1579. doi: 10.2337/diacare.26.5.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.26.5.1553</ArticleId><ArticleId IdType="pubmed">12716821</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R. Autonomic peripheral neuropathy. Lancet. 2005;365:1259&#x2013;1270. doi: 10.1016/S0140-6736(05)74815-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)74815-7</ArticleId><ArticleId IdType="pubmed">15811460</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R. Handbook of Clinical Neurology. Volume 126. Elsevier; Amsterdam, The Netherlands: 2014. Diabetic autonomic neuropathy; pp. 63&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">25410215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nauer M., Thomas A., Morbach S., Niebauer J., Sch&#xf6;nauer U., Thiele H. Cardiac autonomic diabetic neuropathy. Diab. Vasc. Dis. Res. 2008;5:336&#x2013;344. doi: 10.3132/dvdr.2008.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3132/dvdr.2008.047</ArticleId><ArticleId IdType="pubmed">18958844</ArticleId></ArticleIdList></Reference><Reference><Citation>Agashe S., Petak S. Cardiac Autonomic Neuropathy in Diabetes Mellitus. Methodist. Debakey Cardiovasc. J. 2018;14:251&#x2013;256. doi: 10.14797/mdcj-14-4-251.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcj-14-4-251</ArticleId><ArticleId IdType="pmc">PMC6369622</ArticleId><ArticleId IdType="pubmed">30788010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell D.S.H. Detecting and treating the protean manifestations of diabetic autonomic neuropathy. Diabetes Obes. Metab. 2023;25:1162&#x2013;1173. doi: 10.1111/dom.15004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.15004</ArticleId><ArticleId IdType="pubmed">36748121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharucha A.E., Locke G.R., Murray J.A. Diabetes in America. 3rd ed. National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, USA: 2018. Gastrointestinal Manifestations of Diabetes. Chapter 27.</Citation><ArticleIdList><ArticleId IdType="pubmed">33651548</ArticleId></ArticleIdList></Reference><Reference><Citation>Marathe C.S., Jones K.L., Wu T., Rayner C.K., Horowitz M. Gastrointestinal autonomic neuropathy in diabetes. Auton. Neurosci. 2020;229:102718. doi: 10.1016/j.autneu.2020.102718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2020.102718</ArticleId><ArticleId IdType="pubmed">32916479</ArticleId></ArticleIdList></Reference><Reference><Citation>Vita G., Messina C., Savica V., Bellinghieri G. Uraemic autonomic neuropathy. J. Auton. Nerv. Syst. 1990;30:S179&#x2013;S184. doi: 10.1016/0165-1838(90)90127-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1838(90)90127-5</ArticleId><ArticleId IdType="pubmed">2212485</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicki M., Zwiech R., Dryja P., Soba&#x144;ski W. Autonomic neuropathy in hemodialysis patients: Questionnaires versus clinical tests. Clin. Exp. Nephrol. 2009;13:152&#x2013;155. doi: 10.1007/s10157-008-0121-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-008-0121-y</ArticleId><ArticleId IdType="pubmed">19153803</ArticleId></ArticleIdList></Reference><Reference><Citation>Vita G., Bellinghieri G., Trusso A., Costantino G., Santoro D., Monteleone F., Messina C., Savica V. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int. 1999;56:232&#x2013;237. doi: 10.1046/j.1523-1755.1999.00511.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00511.x</ArticleId><ArticleId IdType="pubmed">10411697</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo C., Maule S., Mecca F., Quadri R., Martina G., Cavallo Perin P. The influence of autonomic neuropathy on hypotension during hemodialysis. Clin. Auton. Res. 2002;12:84&#x2013;87. doi: 10.1007/s102860200025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s102860200025</ArticleId><ArticleId IdType="pubmed">12102455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M., Yamada S., Nakamura Y., Oka H., Kamimura T., Nakane S., Tsuruya K., Harada A. Autoimmune autonomic ganglionopathy manifesting as acute-onset orthostatic hypotension in a patient undergoing peritoneal dialysis. CEN Case Rep. 2016;5:5&#x2013;10. doi: 10.1007/s13730-015-0180-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13730-015-0180-3</ArticleId><ArticleId IdType="pmc">PMC5411654</ArticleId><ArticleId IdType="pubmed">28509159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekijima Y., Ueda M., Koike H., Misawa S., Ishii T., Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: Red-flag symptom clusters and treatment algorithm. Orphanet J. Rare Dis. 2018;13:6. doi: 10.1186/s13023-017-0726-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0726-x</ArticleId><ArticleId IdType="pmc">PMC5773042</ArticleId><ArticleId IdType="pubmed">29343286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda M., Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl. Neurodegener. 2014;3:19. doi: 10.1186/2047-9158-3-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2047-9158-3-19</ArticleId><ArticleId IdType="pmc">PMC4165622</ArticleId><ArticleId IdType="pubmed">25228988</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike H., Misu K., Ikeda S., Ando Y., Nakazato M., Ando E., Yamamoto M., Hattori N., Sobue G., Study Group for Hereditary Neuropathy in Japan Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: Early- vs late-onset form. Arch. Neurol. 2002;59:1771&#x2013;1776. doi: 10.1001/archneur.59.11.1771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.59.11.1771</ArticleId><ArticleId IdType="pubmed">12433265</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma J.A., Gonzalez-Duarte A., Kaufmann H. Orthostatic hypotension in hereditary transthyretin amyloidosis: Epidemiology, diagnosis and management. Clin. Auton. Res. 2019;29((Suppl. 1)):33&#x2013;44. doi: 10.1007/s10286-019-00623-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00623-x</ArticleId><ArticleId IdType="pmc">PMC6763509</ArticleId><ArticleId IdType="pubmed">31452021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C.C., Huang C.M., Chiang H.H., Luo K.R., Kan H.W., Yang N.C., Chiang H., Lin W.M., Lai S.M., Lee M.J., et al. Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates. Ann. Neurol. 2015;78:272&#x2013;283. doi: 10.1002/ana.24438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24438</ArticleId><ArticleId IdType="pmc">PMC5034810</ArticleId><ArticleId IdType="pubmed">25973863</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendre T., Plant&#xe9;-Bordeneuve V. Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy. Clin. Auton. Res. 2019;29((Suppl. 1)):25&#x2013;31. doi: 10.1007/s10286-019-00624-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00624-w</ArticleId><ArticleId IdType="pmc">PMC6763624</ArticleId><ArticleId IdType="pubmed">31506870</ArticleId></ArticleIdList></Reference><Reference><Citation>Obici L., Suhr O.B. Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis. Clin. Auton. Res. 2019;29((Suppl. 1)):55&#x2013;63. doi: 10.1007/s10286-019-00628-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00628-6</ArticleId><ArticleId IdType="pmc">PMC6763516</ArticleId><ArticleId IdType="pubmed">31452022</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareyson D., Marchesi C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol. 2009;8:654&#x2013;667. doi: 10.1016/S1474-4422(09)70110-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70110-3</ArticleId><ArticleId IdType="pubmed">19539237</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M., Mauko B., Auer-Grumbach P., Pieber T.R. Molecular genetics of hereditary sensory neuropathies. Neuromol. Med. 2006;8:147&#x2013;158. doi: 10.1385/NMM:8:1-2:147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:8:1-2:147</ArticleId><ArticleId IdType="pubmed">16775373</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhoeven K., Timmerman V., Mauko B., Pieber T.R., De Jonghe P., Auer-Grumbach M. Recent advances in hereditary sensory and autonomic neuropathies. Curr. Opin. Neurol. 2006;19:474&#x2013;480. doi: 10.1097/01.wco.0000245370.82317.f6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000245370.82317.f6</ArticleId><ArticleId IdType="pubmed">16969157</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga N., Kubota M., Miwa Z., Japanese Research Group on Congenital Insensitivity to Pain Hereditary sensory and autonomic neuropathy types IV and V in Japan. Pediatr. Int. 2015;57:30&#x2013;36. doi: 10.1111/ped.12538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.12538</ArticleId><ArticleId IdType="pubmed">25422087</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzlow C., Kazamel M. Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification. Curr. Neurol. Neurosci. Rep. 2019;19:52. doi: 10.1007/s11910-019-0974-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-0974-3</ArticleId><ArticleId IdType="pubmed">31222456</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura N., Kawamura N., Tateishi T., Doi H., Ohyagi Y., Kira J. Predominant parasympathetic involvement in a patient with Charcot-Marie-Tooth disease caused by the MPZ Thr124Met mutation. Rinsho Shinkeigaku. 2009;49:582&#x2013;585. doi: 10.5692/clinicalneurol.49.582.</Citation><ArticleIdList><ArticleId IdType="doi">10.5692/clinicalneurol.49.582</ArticleId><ArticleId IdType="pubmed">19928689</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda N., Noto Y., Kitani-Morii F., Hamano A., Kasai T., Shiga K., Mizuta I., Niwa F., Nakagawa M., Mizuno T. Parasympathetic Dominant Autonomic Dysfunction in Charcot-Marie-Tooth Disease Type 2J with the MPZ Thr124Met Mutation. Intern. Med. 2015;54:1919&#x2013;1922. doi: 10.2169/internalmedicine.54.4259.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.54.4259</ArticleId><ArticleId IdType="pubmed">26234237</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojkovic T., de Seze J., Dubourg O., Arne-Bes M.C., Tardieu S., Hache J.C., Vermersch P. Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin. Neurophysiol. 2003;114:1609&#x2013;1614. doi: 10.1016/S1388-2457(03)00159-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(03)00159-7</ArticleId><ArticleId IdType="pubmed">12948789</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotthier A., Baets J., Timmerman V., Janssens K. Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat. Rev. Neurol. 2012;8:73&#x2013;85. doi: 10.1038/nrneurol.2011.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.227</ArticleId><ArticleId IdType="pubmed">22270030</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M. Hereditary sensory and autonomic neuropathies. Handb. Clin. Neurol. 2013;115:893&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">23931820</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J.H., Hashiguchi A., Yoshimura A., Sakai N., Takahashi M.P., Ueda T., Taniguchi A., Okamoto S., Kanazawa N., Yamamoto Y. WNK1/HSN2 founder mutation in patients with hereditary sensory and autonomic neuropathy: A Japanese cohort study. Clin. Genet. 2017;92:659&#x2013;663. doi: 10.1111/cge.13037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13037</ArticleId><ArticleId IdType="pubmed">28422281</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelrod F.B., Gold-von Simson G. Hereditary sensory and autonomic neuropathies: Types II, III, and IV. Orphanet J. Rare Dis. 2007;2:39. doi: 10.1186/1750-1172-2-39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-2-39</ArticleId><ArticleId IdType="pmc">PMC2098750</ArticleId><ArticleId IdType="pubmed">17915006</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A., Pallar&#xe9;s J.G., Buend&#xed;a-Romero &#xc1;., Mart&#xed;nez-Cava A., Franco-L&#xf3;pez F., S&#xe1;nchez-Alcaraz Mart&#xed;nez B.J., Bernal-Morel E., Courel-Ib&#xe1;&#xf1;ez J. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int. J. Environ. Res. Public Health. 2021;18:5329. doi: 10.3390/ijerph18105329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105329</ArticleId><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel V., Luchsinger V.W., Carvalho G.L., Alcar&#xe1; A.M., Esper N.B., Marinowic D., Zanirati G., da Costa J.C. Guillain-Barr&#xe9; syndrome associated with COVID-19, A systematic review. Brain Behav. Immun. Health. 2023;28:100578. doi: 10.1016/j.bbih.2022.100578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100578</ArticleId><ArticleId IdType="pmc">PMC9842533</ArticleId><ArticleId IdType="pubmed">36686624</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Saif D.S., Ibrahem R.A., Eltabl M.A. Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection. Int. J. Rheum. Dis. 2022;25:1246&#x2013;1253. doi: 10.1111/1756-185X.14409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14409</ArticleId><ArticleId IdType="pmc">PMC9538868</ArticleId><ArticleId IdType="pubmed">35915515</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams R.M.C., Simpson D.M., Navis A., Jette N., Zhou L., Shin S.C. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65:440&#x2013;443. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve. 2022;65:E31&#x2013;E32. doi: 10.1002/mus.27554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27554</ArticleId><ArticleId IdType="pmc">PMC9088382</ArticleId><ArticleId IdType="pubmed">35385125</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., Suarez M.D., Shelly S., Lamotte G.J., Sandroni P., Benarroch E.E., Berini S.E., Cutsforth-Gregory J.K., et al. Autonomic dysfunction following COVID-19 infection: An early experience. Clin. Auton. Res. 2021;31:385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A., Furlanis G., Frezza N.A., Valentinotti R., Ajcevic M., Manganotti P. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: A prospective multidomain observational study. J. Neurol. 2022;269:587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Carneiro D., Rocha I., Habek M., Helbok R., Sellner J., Struhal W., Wenning G., Fanciulli A. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection&#x2014;A systematic review. Eur. J. Neurol. 2023;30:1528&#x2013;1539. doi: 10.1111/ene.15714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15714</ArticleId><ArticleId IdType="pubmed">36694382</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients. Immunol. Res. 2021;69:205&#x2013;211. doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona-Torre F., M&#xed;nguez-Olaondo A., L&#xf3;pez-Bravo A., Tijero B., Grozeva V., Walcker M., Azkune-Galparsoro H., L&#xf3;pez de Munain A., Alcaide A.B., Quiroga J., et al. Dysautonomia in COVID-19 patients: A narrative review on clinical course, diagnostic and therapeutic strategies. Front. Neurol. 2022;13:886609. doi: 10.3389/fneur.2022.886609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.886609</ArticleId><ArticleId IdType="pmc">PMC9198643</ArticleId><ArticleId IdType="pubmed">35720084</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammoul M., Naddour J., Madi A., Reslan M.A., Hatoum F., Zeineddine J., Abou-Kheir W., Lawand N. Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton. Neurosci. 2023;245:103071. doi: 10.1016/j.autneu.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2022.103071</ArticleId><ArticleId IdType="pmc">PMC9789535</ArticleId><ArticleId IdType="pubmed">36580747</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Arnold A.C., Barboi A., Claydon V.E., Limberg J.K., Lucci V.M., Numan M., Peltier A., Snapper H., Vernino S., et al. Long-COVID postural tachycardia syndrome: An American Autonomic Society statement. Clin. Auton. Res. 2021;31:365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G., Ricci F., Recce V., Serio A., Iannetti G., Chahal A.A., St&#xe5;hlberg M., Khanji M.Y., Fedorowski A., Gallina S. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: What do we know? J. Cardiovasc. Dev. Dis. 2021;8:156. doi: 10.3390/jcdd8110156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8110156</ArticleId><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin A., Amah G., Chakroun S., Testard P., Faucher A., Le T.Y.V., Slama D., Le Baut V., Lozeron P., Salmon D., et al. Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of &#x201c;long-COVID&#x201d; patients. Sci. Rep. 2023;13:8251. doi: 10.1038/s41598-023-35086-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35086-8</ArticleId><ArticleId IdType="pmc">PMC10201474</ArticleId><ArticleId IdType="pubmed">37217645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima M., Siokas V., Aloizou A.M., Liampas I., Mentis A.A., Tsouris Z., Papadimitriou A., Mitsias P.D., Tsatsakis A., Bogdanos D.P., et al. Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system. Curr. Treat. Options Neurol. 2020;22:37. doi: 10.1007/s11940-020-00647-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11940-020-00647-z</ArticleId><ArticleId IdType="pmc">PMC7515807</ArticleId><ArticleId IdType="pubmed">32994698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 2022;13:1220. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., David P., Arnheim D., Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun. Rev. 2022;21:103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari A., Hadizadeh A., Islampanah M., Salavati Nik E., Atkin S.L., Sahebkar A. COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis. Autoimmun. Rev. 2023;22:103402. doi: 10.1016/j.autrev.2023.103402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103402</ArticleId><ArticleId IdType="pubmed">37490975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M.S., Johansson A., Jonsson J., Schi&#xf6;th H.B. Dissecting the molecular mechanisms surrounding post-COVID-19 syndrome and neurological features. Int. J. Mol. Sci. 2022;23:4275. doi: 10.3390/ijms23084275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084275</ArticleId><ArticleId IdType="pmc">PMC9028501</ArticleId><ArticleId IdType="pubmed">35457093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou M., Bakola E., Papapostolou A., Stefanou M.I., Gaga M., Zouvelou V., Michopoulos I., Tsivgoulis G. Autonomic dysfunction in long-COVID syndrome: A neurophysiological and neurosonology study. J. Neurol. 2022;269:4611&#x2013;4612. doi: 10.1007/s00415-022-11172-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11172-1</ArticleId><ArticleId IdType="pmc">PMC9086662</ArticleId><ArticleId IdType="pubmed">35536408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruts L., van Koningsveld R., van Doorn P.A. Distinguishing acute-onset CIDP from Guillain-Barr&#xe9; syndrome with treatment related fluctuations. Neurology. 2005;65:138&#x2013;140. doi: 10.1212/01.wnl.0000167549.09664.b8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000167549.09664.b8</ArticleId><ArticleId IdType="pubmed">16009902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten D.M., Suarez G.A., Low P.A., Mandrekar J., Singer W. COMPASS 31, a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin. Proc. 2012;87:1196&#x2013;1201. doi: 10.1016/j.mayocp.2012.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams D., Gonzalez-Duarte A., O&#x2019;Riordan W.D., Yang C.C., Ueda M., Kristen A.V., Tournev I., Schmidt H.H., Coelho T., Berk J.L. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 2018;379:11&#x2013;21. doi: 10.1056/NEJMoa1716153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1716153</ArticleId><ArticleId IdType="pubmed">29972753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimpinski K., Iodice V., Sandroni P., Fealey R.D., Vernino S., Low P.A. Sudomotor dysfunction in autoimmune autonomic ganglionopathy. Neurology. 2009;73:1501&#x2013;1506. doi: 10.1212/WNL.0b013e3181bf995f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bf995f</ArticleId><ArticleId IdType="pmc">PMC2779006</ArticleId><ArticleId IdType="pubmed">19884578</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S., Holmes C., Imrich R. Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations. Auton. Neurosci. 2009;146:18&#x2013;21. doi: 10.1016/j.autneu.2008.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2008.12.004</ArticleId><ArticleId IdType="pmc">PMC4164394</ArticleId><ArticleId IdType="pubmed">19155193</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>